Inspire Medical Systems Key Executives
This section highlights Inspire Medical Systems's key executives, including their titles and compensation details.
Find Contacts at Inspire Medical Systems
(Showing 0 of )
Inspire Medical Systems Earnings
This section highlights Inspire Medical Systems's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-10 | $0.74 | $1.15 |
| Read Transcript | Q3 | 2024 | 2024-11-04 | $0.08 | $0.60 |
| Read Transcript | Q2 | 2024 | 2024-08-06 | $-0.14 | $0.32 |
| Read Transcript | Q1 | 2024 | 2024-05-07 | $-0.63 | $-0.34 |
| Read Transcript | Q4 | 2023 | 2024-02-06 | $-0.09 | $0.49 |
| Read Transcript | Q3 | 2023 | 2023-11-08 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-08-02 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-05-03 | N/A | N/A |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
$147.54
Stock Price
$4.39B
Market Cap
1.25K
Employees
Golden Valley, MN
Location
Financial Statements
Access annual & quarterly financial statements for Inspire Medical Systems, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $802.80M | $624.80M | $407.86M | $233.39M | $115.38M |
| Cost of Revenue | $122.99M | $96.58M | $66.11M | $33.28M | $17.62M |
| Gross Profit | $679.82M | $528.22M | $341.74M | $200.12M | $97.76M |
| Gross Profit Ratio | 84.68% | 84.54% | 83.79% | 85.74% | 84.73% |
| Research and Development Expenses | $114.13M | $116.54M | $68.64M | $37.35M | $26.09M |
| General and Administrative Expenses | $- | $351.66M | $246.39M | $154.81M | $101.47M |
| Selling and Marketing Expenses | $- | $100.30M | $74.30M | $47.80M | $26.40M |
| Selling General and Administrative Expenses | $529.61M | $451.96M | $320.69M | $202.62M | $127.87M |
| Other Expenses | $- | $- | $-49.00K | $-117.00K | $145.00K |
| Operating Expenses | $643.74M | $568.49M | $389.33M | $239.97M | $153.97M |
| Cost and Expenses | $766.72M | $665.07M | $455.45M | $273.24M | $171.59M |
| Interest Income | $23.25M | $20.56M | $5.05M | $125.00K | $1.09M |
| Interest Expense | $22.00K | $- | $1.68M | $2.13M | $2.12M |
| Depreciation and Amortization | $6.55M | $2.85M | $2.90M | $1.99M | $1.81M |
| EBITDA | $65.03M | $-17.06M | $-39.69M | $-38.62M | $-53.16M |
| EBITDA Ratio | 8.10% | -2.73% | -9.73% | -16.55% | -46.07% |
| Operating Income | $36.08M | $-40.27M | $-47.59M | $-39.85M | $-56.21M |
| Operating Income Ratio | 4.49% | -6.45% | -11.67% | -17.07% | -48.72% |
| Total Other Income Expenses Net | $22.37M | $20.36M | $3.32M | $-2.12M | $-880.00K |
| Income Before Tax | $58.45M | $-19.91M | $-44.27M | $-41.97M | $-57.09M |
| Income Before Tax Ratio | 7.28% | -3.19% | -10.85% | -17.98% | -49.48% |
| Income Tax Expense | $4.94M | $1.25M | $613.00K | $72.00K | $115.00K |
| Net Income | $53.51M | $-21.15M | $-44.88M | $-42.04M | $-57.20M |
| Net Income Ratio | 6.67% | -3.39% | -11.00% | -18.01% | -49.58% |
| EPS | $1.80 | $-0.72 | $-1.60 | $-1.54 | $-2.19 |
| EPS Diluted | $1.75 | $-0.72 | $-1.60 | $-1.54 | $-2.19 |
| Weighted Average Shares Outstanding | 29.76M | 29.30M | 28.07M | 27.26M | 26.07M |
| Weighted Average Shares Outstanding Diluted | 30.54M | 29.30M | 28.07M | 27.26M | 26.07M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.72M | $203.19M | $195.88M | $164.01M | $192.51M | $153.30M | $151.09M | $127.90M | $137.90M | $109.19M | $91.39M | $69.38M | $78.40M | $61.69M | $52.96M | $40.35M | $46.01M | $35.84M | $12.18M | $21.35M |
| Cost of Revenue | $35.99M | $32.40M | $29.84M | $24.76M | $28.05M | $24.38M | $24.25M | $19.89M | $22.15M | $19.79M | $14.17M | $10.00M | $11.16M | $8.62M | $7.52M | $5.98M | $7.16M | $5.21M | $1.95M | $3.30M |
| Gross Profit | $203.73M | $170.79M | $166.04M | $139.25M | $164.45M | $128.92M | $126.84M | $108.01M | $115.75M | $89.40M | $77.21M | $59.38M | $67.24M | $53.06M | $45.44M | $34.37M | $38.85M | $30.63M | $10.23M | $18.05M |
| Gross Profit Ratio | 84.99% | 84.06% | 84.77% | 84.91% | 85.43% | 84.10% | 83.95% | 84.45% | 83.94% | 81.88% | 84.49% | 85.58% | 85.77% | 86.02% | 85.80% | 85.18% | 84.44% | 85.46% | 83.96% | 84.56% |
| Research and Development Expenses | $30.34M | $26.08M | $28.86M | $28.85M | $31.05M | $29.14M | $30.82M | $25.52M | $21.25M | $20.99M | $14.53M | $11.87M | $10.29M | $9.61M | $9.29M | $8.15M | $7.29M | $7.31M | $6.06M | $5.44M |
| General and Administrative Expenses | $- | $- | $108.88M | $100.02M | $98.11M | $87.75M | $87.32M | $78.39M | $74.14M | $65.50M | $58.69M | $48.06M | $44.97M | $39.84M | $37.20M | $32.91M | $29.05M | $26.42M | $21.98M | $29.05M |
| Selling and Marketing Expenses | $- | $- | $23.20M | $25.60M | $26.00M | $25.50M | $25.30M | $23.60M | $20.70M | $20.10M | $18.00M | $15.50M | $13.80M | $13.40M | $11.50M | $9.00M | $9.57M | $6.80M | $5.00M | $6.40M |
| Selling General and Administrative Expenses | $141.51M | $130.39M | $132.08M | $125.62M | $124.11M | $113.25M | $112.62M | $101.99M | $94.83M | $85.60M | $76.69M | $63.56M | $58.77M | $53.24M | $48.70M | $41.91M | $38.62M | $33.22M | $26.98M | $29.05M |
| Other Expenses | $- | $- | $-135.00K | $-60.00K | $73.00K | $-224.00K | $-61.00K | $- | $241.00K | $-101.00K | $-144.00K | $-45.00K | $-27.00K | $-33.00K | $-19.00K | $-38.00K | $62.00K | $2.00K | $3.00K | $78.00K |
| Operating Expenses | $171.85M | $156.47M | $160.94M | $154.47M | $155.16M | $142.39M | $143.44M | $127.51M | $116.08M | $106.60M | $91.22M | $75.43M | $69.06M | $62.86M | $57.98M | $50.06M | $45.91M | $40.52M | $33.04M | $34.49M |
| Cost and Expenses | $207.83M | $188.87M | $190.79M | $179.23M | $183.21M | $166.77M | $167.69M | $147.40M | $138.24M | $126.38M | $105.39M | $85.44M | $80.22M | $71.48M | $65.50M | $56.04M | $53.07M | $45.73M | $35.00M | $37.79M |
| Interest Income | $5.55M | $5.89M | $5.88M | $5.92M | $5.87M | $5.50M | $4.92M | $4.27M | $3.37M | $1.35M | $297.00K | $34.00K | $15.00K | $22.00K | $31.00K | $57.00K | $77.00K | $125.00K | $248.00K | $642.00K |
| Interest Expense | $22.00K | $- | $- | $- | $4.29M | $- | $- | $- | $- | $656.00K | $494.00K | $527.00K | $538.00K | $537.00K | $530.00K | $523.00K | $533.00K | $533.00K | $526.00K | $525.00K |
| Depreciation and Amortization | $2.48M | $1.85M | $1.38M | $839.00K | $817.00K | $184.00K | $987.00K | $593.00K | $831.00K | $772.00K | $676.00K | $619.00K | $606.00K | $505.00K | $473.00K | $405.00K | $253.00K | $212.00K | $188.00K | $187.00K |
| EBITDA | $56.75M | $16.17M | $6.48M | $-14.38M | $16.06M | $-13.47M | $-15.94M | $-18.91M | $595.00K | $-15.17M | $-13.18M | $-15.71M | $-1.23M | $-9.30M | $-12.23M | $-15.27M | $-6.81M | $-9.55M | $-22.38M | $-15.53M |
| EBITDA Ratio | 23.68% | 7.96% | 3.31% | -8.77% | 8.34% | -8.79% | -10.55% | -14.78% | 0.43% | -13.90% | -14.42% | -22.64% | -1.57% | -15.08% | -23.09% | -37.83% | -14.80% | -26.65% | -183.66% | -72.76% |
| Operating Income | $31.88M | $14.32M | $5.10M | $-15.22M | $9.30M | $-13.47M | $-16.60M | $-19.50M | $2.71M | $-17.19M | $-14.01M | $-16.06M | $-1.82M | $-9.80M | $-12.54M | $-15.69M | $-7.06M | $-9.89M | $-22.81M | $-16.44M |
| Operating Income Ratio | 13.30% | 7.05% | 2.60% | -9.28% | 4.83% | -8.79% | -10.99% | -15.25% | 1.96% | -15.75% | -15.33% | -23.14% | -2.32% | -15.88% | -23.69% | -38.88% | -15.35% | -27.60% | -187.26% | -77.01% |
| Total Other Income Expenses Net | $4.75M | $6.01M | $5.75M | $5.86M | $5.94M | $5.27M | $4.86M | $4.29M | $3.61M | $593.00K | $-341.00K | $-538.00K | $-550.00K | $-548.00K | $-518.00K | $-504.00K | $-394.00K | $-406.00K | $-275.00K | $195.00K |
| Income Before Tax | $36.64M | $20.33M | $10.85M | $-9.36M | $15.24M | $-8.20M | $-11.74M | $-15.21M | $3.27M | $-16.60M | $-14.35M | $-16.59M | $-2.37M | $-10.34M | $-13.06M | $-16.19M | $-7.46M | $-10.30M | $-23.09M | $-16.25M |
| Income Before Tax Ratio | 15.28% | 10.00% | 5.54% | -5.70% | 7.92% | -5.35% | -7.77% | -11.89% | 2.37% | -15.20% | -15.70% | -23.92% | -3.02% | -16.77% | -24.66% | -40.13% | -16.21% | -28.73% | -189.52% | -76.10% |
| Income Tax Expense | $1.41M | $1.83M | $1.05M | $650.00K | $477.00K | $340.00K | $214.00K | $216.00K | $125.00K | $246.00K | $142.00K | $100.00K | $20.00K | $3.00K | $26.00K | $23.00K | $28.00K | $87.00K | $529.00K | $603.00K |
| Net Income | $35.22M | $18.50M | $9.79M | $-10.01M | $14.76M | $-8.54M | $-11.95M | $-15.42M | $3.15M | $-16.85M | $-14.49M | $-16.69M | $-2.39M | $-10.35M | $-13.09M | $-16.22M | $-7.48M | $-10.38M | $-23.09M | $-16.25M |
| Net Income Ratio | 14.69% | 9.10% | 5.00% | -6.10% | 7.67% | -5.57% | -7.91% | -12.06% | 2.28% | -15.43% | -15.86% | -24.06% | -3.05% | -16.77% | -24.71% | -40.19% | -16.27% | -28.97% | -189.52% | -76.10% |
| EPS | $1.18 | $0.62 | $0.33 | $-0.34 | $0.50 | $-0.29 | $-0.41 | $-0.53 | $0.11 | $-0.60 | $-0.53 | $-0.61 | $-0.09 | $-0.38 | $-0.48 | $-0.60 | $-0.28 | $-0.39 | $-0.88 | $-0.67 |
| EPS Diluted | $1.15 | $0.60 | $0.32 | $-0.34 | $0.49 | $-0.29 | $-0.41 | $-0.53 | $0.10 | $-0.60 | $-0.53 | $-0.61 | $-0.09 | $-0.38 | $-0.48 | $-0.60 | $-0.28 | $-0.39 | $-0.88 | $-0.67 |
| Weighted Average Shares Outstanding | 29.83M | 29.88M | 29.73M | 29.62M | 29.52M | 29.37M | 29.23M | 29.09M | 28.93M | 28.23M | 27.59M | 27.37M | 27.37M | 27.23M | 27.23M | 27.03M | 26.98M | 26.84M | 26.29M | 24.17M |
| Weighted Average Shares Outstanding Diluted | 30.75M | 30.63M | 30.41M | 29.62M | 30.24M | 29.37M | 29.23M | 29.09M | 30.21M | 28.23M | 27.59M | 27.52M | 27.37M | 27.30M | 27.23M | 27.14M | 26.98M | 26.84M | 26.29M | 24.17M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $150.15M | $185.54M | $441.59M | $214.47M | $190.52M |
| Short Term Investments | $295.40M | $274.84M | $9.82M | $- | $43.84M |
| Cash and Short Term Investments | $445.55M | $460.38M | $451.41M | $214.47M | $234.36M |
| Net Receivables | $93.07M | $89.88M | $61.23M | $34.18M | $25.06M |
| Inventory | $80.12M | $33.88M | $11.89M | $17.23M | $8.48M |
| Other Current Assets | $12.07M | $9.60M | $5.50M | $5.32M | $3.93M |
| Total Current Assets | $630.81M | $593.74M | $530.03M | $268.54M | $269.87M |
| Property Plant Equipment Net | $95.24M | $62.65M | $24.13M | $16.41M | $11.12M |
| Goodwill | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- |
| Long Term Investments | $71.00M | $9.14M | $10.50M | $9.94M | $- |
| Tax Assets | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $11.34M | $11.28M | $215.00K | $204.00K | $204.00K |
| Total Non-Current Assets | $177.58M | $83.07M | $34.84M | $26.55M | $11.32M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $808.38M | $676.81M | $564.88M | $295.08M | $281.19M |
| Account Payables | $38.69M | $38.84M | $26.85M | $11.66M | $7.21M |
| Short Term Debt | $- | $- | $1.34M | $9.50M | $- |
| Tax Payables | $1.61M | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- |
| Other Current Liabilities | $48.20M | $39.27M | $33.00M | $20.14M | $13.52M |
| Total Current Liabilities | $88.50M | $78.11M | $61.19M | $41.31M | $20.73M |
| Long Term Debt | $30.04M | $24.85M | $15.07M | $33.39M | $30.63M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $148.00K | $1.35M | $-7.39M | $-8.66M | $85.00K |
| Total Non-Current Liabilities | $30.19M | $26.19M | $7.68M | $24.73M | $30.72M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $118.69M | $104.30M | $68.87M | $66.04M | $51.44M |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $30.00K | $30.00K | $29.00K | $27.00K | $27.00K |
| Retained Earnings | $-291.91M | $-345.42M | $-324.27M | $-279.39M | $-237.35M |
| Accumulated Other Comprehensive Income Loss | $536.00K | $800.00K | $-86.00K | $-55.00K | $29.00K |
| Other Total Stockholders Equity | $981.04M | $917.11M | $820.34M | $508.46M | $467.04M |
| Total Stockholders Equity | $689.70M | $572.51M | $496.01M | $229.05M | $229.75M |
| Total Equity | $689.70M | $572.51M | $496.01M | $229.05M | $229.75M |
| Total Liabilities and Stockholders Equity | $808.38M | $676.81M | $564.88M | $295.08M | $281.19M |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $808.38M | $676.81M | $564.88M | $295.08M | $281.19M |
| Total Investments | $366.39M | $283.98M | $9.82M | $9.94M | $43.84M |
| Total Debt | $30.04M | $24.85M | $8.87M | $33.78M | $30.63M |
| Net Debt | $-120.11M | $-160.69M | $-432.72M | $-180.68M | $-159.89M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $150.15M | $147.51M | $188.03M | $175.42M | $185.54M | $329.90M | $467.05M | $442.13M | $441.59M | $417.81M | $186.57M | $203.29M | $214.47M | $210.20M | $176.54M | $182.35M | $190.52M | $178.71M | $211.24M | $76.12M |
| Short Term Investments | $295.40M | $263.48M | $251.63M | $265.94M | $274.84M | $134.32M | $- | $9.93M | $9.82M | $9.74M | $9.75M | $- | $- | $- | $31.30M | $43.80M | $43.84M | $55.93M | $31.32M | $59.61M |
| Cash and Short Term Investments | $445.55M | $410.99M | $439.66M | $441.36M | $460.38M | $464.21M | $467.05M | $452.06M | $451.41M | $427.55M | $196.32M | $203.29M | $214.47M | $210.20M | $207.84M | $226.14M | $234.36M | $234.64M | $242.56M | $135.72M |
| Net Receivables | $93.07M | $89.74M | $79.72M | $72.33M | $89.88M | $71.46M | $63.50M | $59.77M | $61.23M | $48.50M | $40.38M | $34.54M | $34.18M | $26.68M | $24.91M | $21.65M | $25.06M | $21.10M | $10.23M | $11.03M |
| Inventory | $80.12M | $67.43M | $59.02M | $48.97M | $33.88M | $26.11M | $20.84M | $15.66M | $11.89M | $15.15M | $21.86M | $22.20M | $17.23M | $15.57M | $13.30M | $11.38M | $8.48M | $8.97M | $9.97M | $7.25M |
| Other Current Assets | $12.07M | $14.36M | $28.75M | $9.55M | $9.60M | $7.80M | $8.69M | $6.09M | $5.50M | $8.70M | $4.57M | $2.44M | $5.32M | $6.09M | $6.90M | $3.22M | $3.93M | $4.44M | $8.70M | $2.86M |
| Total Current Assets | $630.81M | $582.52M | $607.16M | $572.21M | $593.74M | $569.59M | $560.08M | $533.58M | $530.03M | $495.54M | $263.13M | $262.48M | $268.54M | $255.50M | $249.49M | $260.78M | $269.87M | $266.92M | $267.11M | $155.43M |
| Property Plant Equipment Net | $95.24M | $89.26M | $83.89M | $74.53M | $62.65M | $55.33M | $46.59M | $27.53M | $24.13M | $21.27M | $18.41M | $16.99M | $16.41M | $13.21M | $12.53M | $12.43M | $11.12M | $4.48M | $3.73M | $3.79M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $71.00M | $113.42M | $36.74M | $38.20M | $9.14M | $2.96M | $10.80M | $- | $10.50M | $10.50M | $10.30M | $9.80M | $9.94M | $9.98M | $9.98M | $- | $- | $- | $- | $6.14M |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $11.34M | $10.99M | $595.00K | $896.00K | $11.28M | $11.61M | $785.00K | $10.73M | $215.00K | $204.00K | $154.00K | $454.00K | $204.00K | $204.00K | $204.00K | $204.00K | $204.00K | $381.00K | $469.00K | $381.00K |
| Total Non-Current Assets | $177.58M | $213.67M | $121.23M | $113.63M | $83.07M | $69.90M | $58.17M | $38.27M | $34.84M | $31.98M | $28.87M | $27.24M | $26.55M | $23.40M | $22.71M | $12.63M | $11.32M | $4.86M | $4.20M | $10.30M |
| Other Assets | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-0 | $- | $- | $- | $- |
| Total Assets | $808.38M | $796.19M | $728.39M | $685.84M | $676.81M | $639.49M | $618.25M | $571.85M | $564.88M | $527.52M | $292.00M | $289.72M | $295.08M | $278.89M | $272.21M | $273.41M | $281.19M | $271.78M | $271.31M | $165.74M |
| Account Payables | $38.69M | $34.93M | $33.62M | $43.80M | $38.84M | $40.03M | $39.96M | $36.48M | $26.85M | $20.30M | $16.03M | $17.02M | $11.66M | $9.99M | $8.68M | $9.06M | $7.21M | $6.74M | $5.10M | $5.82M |
| Short Term Debt | $- | $- | $- | $- | $- | $- | $1.31M | $1.37M | $1.34M | $1.25M | $13.32M | $12.92M | $9.50M | $6.15M | $3.06M | $- | $- | $85.00K | $338.00K | $585.00K |
| Tax Payables | $1.61M | $1.84M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- | $- | $-1.31M | $- | $- | $- | $- | $- | $312.00K | $- | $- | $- | $- | $- | $- | $- |
| Other Current Liabilities | $48.20M | $37.50M | $32.04M | $28.37M | $39.27M | $29.96M | $25.41M | $22.02M | $33.00M | $27.74M | $17.50M | $13.22M | $20.14M | $17.45M | $12.61M | $10.37M | $13.52M | $11.37M | $7.60M | $7.31M |
| Total Current Liabilities | $88.50M | $74.26M | $65.66M | $72.17M | $78.11M | $70.00M | $66.69M | $59.87M | $61.19M | $49.29M | $46.85M | $43.17M | $41.31M | $33.59M | $24.35M | $19.42M | $20.73M | $18.20M | $13.04M | $13.72M |
| Long Term Debt | $30.04M | $25.22M | $49.02M | $24.50M | $49.69M | $50.35M | $44.11M | $7.18M | $15.07M | $15.76M | $26.24M | $29.90M | $33.39M | $24.88M | $33.87M | $30.76M | $30.63M | $24.69M | $24.63M | $24.58M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $148.00K | $150.00K | $-24.36M | $146.00K | $-23.50M | $-25.03M | $-21.91M | $146.00K | $-7.39M | $-7.74M | $-8.08M | $-8.41M | $-8.66M | $124.00K | $-5.92M | $97.00K | $85.00K | $74.00K | $40.00K | $40.00K |
| Total Non-Current Liabilities | $30.19M | $25.37M | $24.66M | $24.65M | $26.19M | $25.32M | $22.20M | $7.33M | $7.68M | $8.03M | $18.16M | $21.50M | $24.73M | $25.00M | $27.94M | $30.86M | $30.72M | $24.76M | $24.67M | $24.62M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $0 | $- | $- | $- | $- |
| Total Liabilities | $118.69M | $99.63M | $90.32M | $96.82M | $104.30M | $95.31M | $88.89M | $67.20M | $68.87M | $57.32M | $65.02M | $64.67M | $66.04M | $58.59M | $52.29M | $50.28M | $51.44M | $42.96M | $37.71M | $38.33M |
| Preferred Stock | $- | $- | $- | $- | $916.31M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $30.00K | $30.00K | $30.00K | $30.00K | $30.00K | $29.00K | $29.00K | $29.00K | $29.00K | $29.00K | $28.00K | $28.00K | $27.00K | $27.00K | $27.00K | $27.00K | $27.00K | $27.00K | $27.00K | $24.00K |
| Retained Earnings | $-291.91M | $-327.14M | $-345.63M | $-355.43M | $-345.42M | $-360.19M | $-351.65M | $-339.69M | $-324.27M | $-327.42M | $-310.57M | $-296.08M | $-279.39M | $-277.00M | $-266.65M | $-253.56M | $-237.35M | $-229.86M | $-219.48M | $-196.39M |
| Accumulated Other Comprehensive Income Loss | $536.00K | $1.70M | $-115.00K | $124.00K | $800.00K | $44.00K | $103.00K | $32.00K | $-86.00K | $-363.00K | $-201.00K | $-198.00K | $-55.00K | $-9.00K | $-12.00K | $9.00K | $29.00K | $73.00K | $154.00K | $295.00K |
| Other Total Stockholders Equity | $981.04M | $1.02B | $983.79M | $944.30M | $917.11M | $904.29M | $880.87M | $844.28M | $820.34M | $797.96M | $537.73M | $521.31M | $508.46M | $497.28M | $486.55M | $476.66M | $467.04M | $458.59M | $452.89M | $323.47M |
| Total Stockholders Equity | $689.70M | $696.56M | $638.07M | $589.02M | $572.51M | $544.18M | $529.36M | $504.65M | $496.01M | $470.20M | $226.98M | $225.06M | $229.05M | $220.30M | $219.91M | $223.13M | $229.75M | $228.82M | $233.59M | $127.40M |
| Total Equity | $689.70M | $696.56M | $638.07M | $589.02M | $572.51M | $544.18M | $529.36M | $504.65M | $496.01M | $470.20M | $226.98M | $225.06M | $229.05M | $220.30M | $219.91M | $223.13M | $229.75M | $228.82M | $233.59M | $127.40M |
| Total Liabilities and Stockholders Equity | $808.38M | $796.19M | $728.39M | $685.84M | $676.81M | $639.49M | $618.25M | $571.85M | $564.88M | $527.52M | $292.00M | $289.72M | $295.08M | $278.89M | $272.21M | $273.41M | $281.19M | $271.78M | $271.31M | $165.74M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $808.38M | $796.19M | $728.39M | $685.84M | $676.81M | $639.49M | $618.25M | $571.85M | $564.88M | $527.52M | $292.00M | $289.72M | $295.08M | $278.89M | $272.21M | $273.41M | $281.19M | $271.78M | $271.31M | $165.74M |
| Total Investments | $366.39M | $376.90M | $288.37M | $304.15M | $283.98M | $137.28M | $10.80M | $9.93M | $9.82M | $9.74M | $9.75M | $9.80M | $9.94M | $9.98M | $41.27M | $43.80M | $43.84M | $55.93M | $31.32M | $65.75M |
| Total Debt | $30.04M | $25.33M | $24.51M | $24.50M | $24.85M | $25.17M | $23.37M | $8.55M | $8.87M | $9.13M | $31.34M | $34.27M | $33.78M | $31.03M | $30.90M | $30.76M | $30.63M | $24.77M | $24.97M | $25.16M |
| Net Debt | $-120.11M | $-122.19M | $-163.52M | $-150.92M | $-160.69M | $-304.72M | $-443.68M | $-433.58M | $-432.72M | $-408.68M | $-155.23M | $-169.02M | $-180.68M | $-179.17M | $-145.65M | $-151.59M | $-159.89M | $-153.93M | $-186.27M | $-50.96M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $53.51M | $-21.15M | $-44.88M | $-42.04M | $-57.20M |
| Depreciation and Amortization | $6.55M | $2.85M | $1.86M | $1.22M | $840.00K |
| Deferred Income Tax | $- | $- | $- | $14.00K | $-22.00K |
| Stock Based Compensation | $116.01M | $82.47M | $51.97M | $26.18M | $12.82M |
| Change in Working Capital | $-37.71M | $-40.78M | $1.81M | $-6.86M | $-10.88M |
| Accounts Receivables | $-2.60M | $-30.22M | $-27.02M | $-9.24M | $-11.84M |
| Inventory | $-46.23M | $-22.00M | $5.34M | $-8.75M | $-2.65M |
| Accounts Payables | $604.00K | $9.30M | $14.36M | $4.78M | $2.05M |
| Other Working Capital | $10.52M | $2.14M | $9.13M | $6.36M | $1.56M |
| Other Non Cash Items | $-8.11M | $1.27M | $812.00K | $1.37M | $1.40M |
| Net Cash Provided by Operating Activities | $130.25M | $24.65M | $11.57M | $-20.12M | $-53.05M |
| Investments in Property Plant and Equipment | $-39.12M | $-23.63M | $-9.10M | $-4.67M | $-2.46M |
| Acquisitions Net | $- | $- | $- | $-33.81M | $-89.08M |
| Purchases of Investments | $-418.60M | $-281.44M | $-10.50M | $-9.99M | $-52.72M |
| Sales Maturities of Investments | $344.61M | $10.25M | $- | $43.80M | $141.80M |
| Other Investing Activities | $- | $- | $-10.50M | $33.81M | $89.08M |
| Net Cash Used for Investing Activities | $-113.12M | $-294.82M | $-19.60M | $29.14M | $86.63M |
| Debt Repayment | $- | $- | $-24.50M | $- | $- |
| Common Stock Issued | $- | $31.11M | $243.80M | $14.95M | $124.65M |
| Common Stock Repurchased | $-75.00M | $-17.16M | $- | $3.47M | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $22.61M | $13.95M | $15.78M | $14.95M | $9.41M |
| Net Cash Used Provided by Financing Activities | $-52.39M | $13.95M | $235.08M | $14.95M | $134.06M |
| Effect of Forex Changes on Cash | $-118.00K | $164.00K | $75.00K | $-19.00K | $11.00K |
| Net Change in Cash | $-35.39M | $-256.06M | $227.12M | $23.95M | $167.66M |
| Cash at End of Period | $150.15M | $185.54M | $441.59M | $214.47M | $190.52M |
| Cash at Beginning of Period | $185.54M | $441.59M | $214.47M | $190.52M | $22.86M |
| Operating Cash Flow | $130.25M | $24.65M | $11.57M | $-20.12M | $-53.05M |
| Capital Expenditure | $-39.12M | $-23.63M | $-9.10M | $-4.67M | $-2.46M |
| Free Cash Flow | $91.12M | $1.02M | $2.47M | $-24.79M | $-55.50M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $35.22M | $18.50M | $9.79M | $-10.01M | $14.76M | $-8.54M | $-11.95M | $-15.42M | $3.15M | $-16.85M | $-14.49M | $-16.69M | $-2.39M | $-10.35M | $-13.09M | $-16.22M | $-7.48M | $-10.38M | $-23.09M | $-16.25M |
| Depreciation and Amortization | $2.48M | $1.85M | $1.38M | $839.00K | $817.00K | $777.00K | $659.00K | $593.00K | $569.00K | $513.00K | $417.00K | $359.00K | $344.00K | $336.00K | $304.00K | $234.00K | $253.00K | $212.00K | $188.00K | $187.00K |
| Deferred Income Tax | $- | $- | $- | $- | $-2.47M | $-6.17M | $- | $- | $- | $- | $- | $- | $-1.00K | $-8.00K | $-7.00K | $30.00K | $44.00K | $22.00K | $-8.00K | $-80.00K |
| Stock Based Compensation | $29.14M | $28.22M | $32.32M | $26.32M | $22.85M | $19.83M | $21.57M | $18.32M | $15.00M | $14.59M | $12.66M | $9.72M | $7.03M | $6.81M | $6.34M | $6.00M | $3.85M | $3.31M | $2.90M | $2.75M |
| Change in Working Capital | $3.10M | $5.68M | $-41.54M | $-4.95M | $-19.90M | $-9.30M | $-6.48M | $-5.09M | $200.00K | $13.02M | $-4.87M | $-6.53M | $-4.65M | $2.50M | $-3.96M | $-740.00K | $-1.14M | $-2.46M | $-5.61M | $-1.67M |
| Accounts Receivables | $-3.95M | $-9.90M | $-7.71M | $18.96M | $-18.63M | $-8.47M | $-4.61M | $1.49M | $-12.62M | $-8.19M | $-5.83M | $-382.00K | $-7.50M | $-1.87M | $-3.25M | $3.38M | $-3.92M | $-10.83M | $813.00K | $2.09M |
| Inventory | $-12.69M | $-8.41M | $-10.05M | $-15.09M | $-7.77M | $-5.27M | $-5.18M | $-3.78M | $3.26M | $6.71M | $342.00K | $-4.97M | $-1.66M | $-2.28M | $-1.91M | $-2.90M | $487.00K | $999.00K | $-2.72M | $-1.41M |
| Accounts Payables | $3.96M | $1.65M | $-8.56M | $3.56M | $-1.78M | $-707.00K | $3.39M | $8.39M | $5.75M | $4.85M | $-1.76M | $5.52M | $1.29M | $1.30M | $712.00K | $1.48M | $-214.00K | $1.62M | $-733.00K | $1.37M |
| Other Working Capital | $15.78M | $22.34M | $-15.21M | $-12.38M | $8.28M | $5.15M | $-92.00K | $-11.19M | $3.81M | $9.65M | $2.38M | $-6.71M | $3.21M | $5.35M | $493.00K | $-2.69M | $2.51M | $5.75M | $-2.97M | $-3.72M |
| Other Non Cash Items | $-766.00K | $-1.97M | $59.38M | $17.23M | $1.21M | $7.05M | $1.30M | $264.00K | $349.00K | $-268.00K | $331.00K | $400.00K | $406.00K | $371.00K | $297.00K | $294.00K | $364.00K | $389.00K | $368.00K | $280.00K |
| Net Cash Provided by Operating Activities | $69.18M | $52.28M | $-78.00K | $8.86M | $17.27M | $3.64M | $5.09M | $-1.34M | $19.27M | $11.00M | $-5.95M | $-12.75M | $734.00K | $-338.00K | $-10.11M | $-10.40M | $-4.11M | $-8.91M | $-25.25M | $-14.78M |
| Investments in Property Plant and Equipment | $-7.03M | $-8.01M | $-12.39M | $-11.70M | $-8.03M | $-6.99M | $-4.86M | $-3.75M | $-2.95M | $-3.51M | $-1.42M | $-1.22M | $-533.00K | $-1.15M | $-1.66M | $-1.32M | $-604.00K | $-1.22M | $-381.00K | $-255.00K |
| Acquisitions Net | $- | $- | $- | $- | $143.69M | $- | $-10.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Purchases of Investments | $-81.06M | $-225.50M | $-56.30M | $-55.74M | $-143.94M | $-137.25M | $-250.00K | $- | $- | $-250.00K | $-10.00M | $-250.00K | $- | $- | $-9.99M | $- | $- | $-37.81M | $- | $-14.91M |
| Sales Maturities of Investments | $91.85M | $130.54M | $74.31M | $47.90M | $246.00K | $- | $10.00M | $- | $- | $- | $- | $- | $- | $31.30M | $12.50M | $- | $12.00M | $13.10M | $34.30M | $82.40M |
| Other Investing Activities | $- | $- | $18.01M | $-7.84M | $-143.69M | $-137.25M | $10.00M | $- | $- | $-250.00K | $-10.00M | $-250.00K | $- | $31.30M | $2.51M | $- | $12.00M | $-24.71M | $34.30M | $67.50M |
| Net Cash Used for Investing Activities | $3.76M | $-102.97M | $5.62M | $-19.54M | $-151.72M | $-144.24M | $4.89M | $-3.75M | $-2.95M | $-3.76M | $-11.42M | $-1.47M | $-533.00K | $30.15M | $844.00K | $-1.32M | $11.40M | $-25.93M | $33.92M | $67.24M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-21.44M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $14.22M | $8.95M | $3.62M | $3.81M | $4.02M | $15.90M | $- | $251.09M | $1.76M | $3.68M | $3.09M | $11.48M | $3.84M | $3.48M | $3.55M | $7.05M | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $-1.86M | $-2.85M | $-13.93M | $-516.00K | $-971.00K | $- | $3.74M | $- | $- | $-43.00K | $3.47M | $- | $- | $- | $2.36M | $- | $- | $- |
| Dividends Paid | $- | $- | $-5.88M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-70.14M | $-4.33M | $12.97M | $768.00K | $-10.12M | $3.50M | $14.93M | $5.63M | $7.29M | $245.56M | $619.00K | $3.04M | $4.08M | $3.84M | $3.48M | $3.55M | $4.52M | $2.31M | $126.44M | $787.00K |
| Net Cash Used Provided by Financing Activities | $-70.14M | $9.89M | $7.09M | $768.00K | $-10.12M | $3.50M | $14.93M | $5.63M | $7.29M | $224.12M | $619.00K | $3.04M | $4.08M | $3.84M | $3.48M | $3.55M | $4.52M | $2.31M | $126.44M | $787.00K |
| Effect of Forex Changes on Cash | $-166.00K | $272.00K | $-10.00K | $-214.00K | $211.00K | $-51.00K | $-2.00K | $6.00K | $176.00K | $-127.00K | $33.00K | $-7.00K | $-10.00K | $5.00K | $-16.00K | $2.00K | $6.00K | $-6.00K | $7.00K | $4.00K |
| Net Change in Cash | $2.64M | $-40.52M | $12.62M | $-10.12M | $-144.36M | $-137.15M | $24.92M | $540.00K | $23.78M | $231.24M | $-16.72M | $-11.18M | $4.27M | $33.66M | $-5.81M | $-8.17M | $11.81M | $-32.53M | $135.12M | $53.26M |
| Cash at End of Period | $150.15M | $147.51M | $188.03M | $175.42M | $185.54M | $329.90M | $467.05M | $442.13M | $441.59M | $417.81M | $186.57M | $203.29M | $214.47M | $210.20M | $176.54M | $182.35M | $190.52M | $178.71M | $211.24M | $76.12M |
| Cash at Beginning of Period | $147.51M | $188.03M | $175.42M | $185.54M | $329.90M | $467.05M | $442.13M | $441.59M | $417.81M | $186.57M | $203.29M | $214.47M | $210.20M | $176.54M | $182.35M | $190.52M | $178.71M | $211.24M | $76.12M | $22.86M |
| Operating Cash Flow | $69.18M | $52.28M | $-78.00K | $8.86M | $17.27M | $3.64M | $5.09M | $-1.34M | $19.27M | $11.00M | $-5.95M | $-12.75M | $734.00K | $-338.00K | $-10.11M | $-10.40M | $-4.11M | $-8.91M | $-25.25M | $-14.78M |
| Capital Expenditure | $-7.03M | $-8.01M | $-12.39M | $-11.70M | $-8.03M | $-6.99M | $-4.86M | $-3.75M | $-2.95M | $-3.51M | $-1.42M | $-1.22M | $-533.00K | $-1.15M | $-1.66M | $-1.32M | $-604.00K | $-1.22M | $-381.00K | $-255.00K |
| Free Cash Flow | $62.15M | $44.28M | $-12.47M | $-2.84M | $9.23M | $-3.35M | $237.00K | $-5.10M | $16.32M | $7.49M | $-7.37M | $-13.96M | $201.00K | $-1.49M | $-11.78M | $-11.72M | $-4.71M | $-10.12M | $-25.63M | $-15.03M |
Inspire Medical Systems Dividends
Explore Inspire Medical Systems's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
-
Dividend Payout Ratio
-
Dividend Paid & Capex Coverage Ratio
3.33x
Inspire Medical Systems Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $9 | $9 | January 09, 2008 | November 21, 2007 |
Inspire Medical Systems News
Read the latest news about Inspire Medical Systems, including recent articles, headlines, and updates.
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m.
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
MINNEAPOLIS, March 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 18, 2025.
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire Medical”) on behalf of the company's long-term shareholders.
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88%
The consensus price target hints at a 25.9% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital Markets Jon Block - Stifel Michael Polark - Wolfe Research Mike Kratky - Leerink Partners Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. My name is Dilem [ph] and I'll be your conference operator today.
Inspire Medical's Earnings Surge in Q4
Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate.
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024
Countdown to Inspire (INSP) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top -and-bottom-line estimates for Inspire (INSP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance
Inspire Reports Year-over-Year Revenue Growth of 25% for the Fourth Quarter and 28% for the Full Year 2024 Inspire Reports Year-over-Year Revenue Growth of 25% for the Fourth Quarter and 28% for the Full Year 2024
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.
Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors
SAN MATEO, Calif.--(BUSINESS WIRE)-- #backpain--Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will join its Board of Directors. Rick is the Chief Financial Officer of Inspire Medical Systems, Inc. (NYSE: INSP), where he has played a pivotal role in driving strategic financial and operational growth for the global leader in the development and commercialization of innovative, minimally invasive solutions fo.
UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program
MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase (“ASR”) transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company's common stock, par value $0.001 per share. The ASR transaction is being completed pursuant to a previously announced $150.0 million share repurchase program authorized by the Company's Board of Directors.
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Ezgi Yagci – Vice President-Investor Relations Tim Herbert – President and Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Danielle Antalffy – UBS Travis Steed – Bank of America Securities Adam Maeder – Piper Sandler David Rescott – Baird Michael Sarcone – Jefferies Richard Newitter – Truist Securities Larry Biegelsen – Wells Fargo Shagun Singh – RBC Kallum Titchmarsh – Morgan Stanley Jon Block – Stifel Anthony Petrone – Mizuho Americas Brett Fishbin – KeyBanc Capital Markets Chris Pasquale – Nephron Research Michael Polark – Wolfe Research Mike Kratky – Leerink Partners Suraj Kalia – Oppenheimer & Co Operator Good afternoon. My name is Dilem, and I'll be your conference operator today.
Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for INSP.